Insulet (NASDAQ:PODD – Get Rating) had its target price lifted by Raymond James from $320.00 to $334.00 in a research report released on Friday morning, The Fly reports. They currently have an outperform rating on the medical instruments supplier’s stock. A number of other research analysts have also recently issued reports on the stock. Canaccord […]
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Advisor Group Holdings Inc. increased its position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 15.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,484 shares of the medical instruments supplier’s stock after buying an additional 856 shares during […]
Insulet Co. (NASDAQ:PODD – Get Rating) Director Shacey Petrovic sold 15,000 shares of the business’s stock in a transaction on Friday, July 1st. The shares were sold at an average price of $222.90, for a total transaction of $3,343,500.00. Following the transaction, the director now owns 13,695 shares in the company, valued at approximately $3,052,615.50. […]
Fifth Third Bancorp increased its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 10.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,287 shares of the medical instruments supplier’s stock after buying an additional 209 shares during the quarter. Fifth […]